Sort   by:  
 Page size 
UnknownElevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson's disease.
Not available
S-EPMC10073226 | biostudies-literature
UnknownNeuronal α-Synuclein Disease Stage Progression over 5 Years.
Not available
S-EPMC12273616 | biostudies-literature
UnknownDasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622.
Not available
S-EPMC6067800 | biostudies-literature
UnknownSeed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression.
Not available
S-EPMC8530949 | biostudies-literature
UnknownInduction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children's Oncology Group study P9934.
Not available
S-EPMC3434977 | biostudies-literature
UnknownCollaboration and knowledge integration for successful brain therapeutics - lessons learned from the pandemic.
Not available
S-EPMC9844134 | biostudies-literature
UnknownThe effect of LRRK2 loss-of-function variants in humans.
Not available
S-EPMC7303015 | biostudies-literature
UnknownNeuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts.
Not available
S-EPMC11567150 | biostudies-literature
UnknownAssociation of Sex and Age With Mild Traumatic Brain Injury-Related Symptoms: A TRACK-TBI Study.
Not available
S-EPMC8025125 | biostudies-literature
UnknownGenome of the long-living sacred lotus (Nelumbo nucifera Gaertn.).
Not available
S-EPMC4053705 | biostudies-literature
Sort   by:  
 Page size